Jiangsu, China

Guangjun Sun

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Location History:

  • Shanghai, CN (2019)
  • Jiangsu, CN (2021 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Guangjun Sun: A Pioneer in FGFR4 Inhibition and Apoptosis Regulation

Introduction

Guangjun Sun, an innovative inventor based in Jiangsu, China, has made significant contributions to the field of pharmaceuticals through his research and inventions. With a remarkable portfolio of four patents, Sun has focused his efforts on developing new therapeutic agents aimed at treating various cancers and other diseases.

Latest Patents

Among his latest patents, Sun has developed an FGFR4 inhibitor, characterized by a specific structure outlined in formula (I). This compound exhibits a strong inhibitory effect on FGFR4 kinase activity and showcases high selectivity, making it a promising candidate for drug development against several types of cancers, including liver, stomach, prostate, skin, ovarian, lung, breast, and colon cancers. Additionally, he has worked on substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors. This patent involves an amide derivative inhibitor and its preparation method, which is targeted at treating neurodegenerative diseases, cardiovascular issues, inflammation, autoimmune disorders, and metabolic diseases.

Career Highlights

During his career, Guangjun Sun has been associated with prominent pharmaceutical companies such as Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His work at these institutions has not only advanced his personal research but also contributed to the wider pharmaceutical landscape.

Collaborations

Sun has collaborated with notable colleagues, including Peng Gao and Rudi Bao, enhancing his research through collaborative efforts. These partnerships have allowed for a pooling of knowledge and expertise, facilitating innovative advancements in medical science.

Conclusion

Guangjun Sun stands out in the realm of pharmaceutical innovations, particularly with his focus on FGFR4 inhibitors and other therapeutic applications. His contributions are expected to pave the way for new treatment options in the fight against cancer and various diseases, reflecting a commitment to medical advancement and improved patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…